The blood collection market plays a crucial role in modern healthcare systems by enabling accurate disease diagnosis, monitoring, and treatment management. Blood sampling is one of the most commonly performed medical procedures worldwide, forming the foundation of laboratory diagnostics, transfusion medicine, and disease surveillance.

In 2024, the global blood collection market was valued at US$ 7.4 Bn. The industry is projected to expand at a CAGR of 6.4% from 2025 to 2035, reaching approximately US$ 14.6 Bn by the end of 2035. Rising demand for diagnostic testing, increasing prevalence of chronic and infectious diseases, and technological advancements in automated blood collection systems are key factors driving market growth.

Market Drivers and Growth Factors

1. Rising Demand for Diagnostic Testing

The growing burden of infectious diseases, respiratory disorders, urinary tract infections (UTIs), sexually transmitted infections (STIs), and gastrointestinal conditions has significantly increased laboratory testing volumes. Blood tests remain essential for disease detection, monitoring, and treatment planning.

Additionally, the expansion of preventive healthcare programs and routine health check-ups is contributing to higher blood sample collection rates worldwide.

2. Growth in Chronic and Lifestyle Diseases

Chronic conditions such as diabetes, cardiovascular diseases, and metabolic disorders require frequent blood monitoring. This recurring need fuels consistent demand for blood collection needles, tubes, lancets, and automated systems.

3. Technological Advancements

Automation in blood collection is transforming the industry. Automated systems reduce human error, improve sample quality, and enhance workflow efficiency in diagnostic centers and hospitals. The adoption of vacuum-based blood collection tubes and safety-engineered devices is further supporting market growth.

4. Expansion of Blood Banks and Transfusion Services

The increasing number of surgeries, trauma cases, and cancer treatments has heightened the demand for blood transfusions. As a result, blood banks and donation centers are expanding their infrastructure, directly boosting demand for blood bags and collection accessories.

Get Sample PDF Copy: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=33059

Market Segmentation Analysis

By Product Type

The blood collection market is segmented into:

• Blood Collection Needles and Syringes
• Blood Collection Tubes
• Blood Collection Lancets
• Blood Bags
• Others (Blood Culture Bottles, etc.)

Among these, blood collection tubes hold a significant share due to their widespread use in diagnostic laboratories. Innovations in additive technologies and vacuum systems are improving sample preservation and accuracy.

Blood bags are also witnessing strong demand, particularly in transfusion services and blood banks.

By Collection Method

• Automated
• Manual

Manual blood collection remains dominant, especially in developing regions due to cost-effectiveness. However, automated systems are gaining momentum in advanced healthcare settings because of their efficiency and safety benefits.

By Application

Key applications include:

• Disease Diagnosis & Management
• Respiratory Diseases
• Sexually Transmitted Infections (STIs)
• Urinary Tract Infections (UTIs)
• Gastrointestinal Testing
• Infectious Disease Testing
• Drug and Alcohol Testing
• Medication Management
• Pain and Rehabilitation Management
• Metabolomics

Disease diagnosis and infectious disease testing represent the largest application segments, driven by the increasing need for early detection and monitoring.

By Blood Collection Site

• Venous
• Capillary

Venous blood collection dominates the market due to its reliability and suitability for a wide range of diagnostic tests. Capillary collection is commonly used for point-of-care testing and pediatric applications.

By End-user

• Hospitals
• Diagnostic Centers
• Blood Banks
• Others

Hospitals and diagnostic centers collectively account for the largest share, owing to high patient volumes and expanding laboratory capabilities.

Regional Outlook

The blood collection market demonstrates strong growth across all major regions:

• North America leads due to advanced healthcare infrastructure, high testing volumes, and strong presence of major industry players.
• Europe follows closely with robust regulatory frameworks and well-established healthcare systems.
• Asia Pacific is expected to witness the fastest growth, driven by rising healthcare investments, expanding laboratory networks, and increasing disease awareness.
• Latin America and the Middle East & Africa are gradually expanding due to improving healthcare access.

Countries covered in market analysis include the U.S., Canada, Germany, U.K., France, Italy, Spain, China, India, Japan, South Korea, Brazil, Mexico, GCC countries, and South Africa.

Competitive Landscape

The blood collection market is moderately competitive, with leading players focusing on product innovation, safety enhancement, and strategic partnerships.

Major companies profiled include:

• Abbott Laboratories
• Becton, Dickinson and Company (BD)
• Terumo Corp.
• Medtronic Plc
• Qiagen
• Greiner Holding AG
• Haemonetics Corp.
• Sarstedt AG & Co.
• ICU Medical, Inc.
• SB-KAWASUMI LABORATORIES, INC.
• Mitra Industries Private Limited
• FL Medical s.r.l.
• CML Biotech

These companies are investing in advanced safety-engineered devices, expanding global distribution networks, and enhancing automation capabilities to strengthen market presence.

Future Outlook

The blood collection market is poised for steady growth through 2035. Increasing emphasis on preventive healthcare, growing adoption of minimally invasive techniques, and rising demand for accurate diagnostic testing will continue to shape the industry.

Moreover, innovations in micro-sampling, point-of-care testing, and digital integration within laboratories are expected to open new growth opportunities.

Frequently Asked Questions (FAQs)

1. What is the current size of the global blood collection market?

The market was valued at US$ 7.4 Bn in 2024.

2. What is the projected market value by 2035?

The market is expected to reach US$ 14.6 Bn by the end of 2035, growing at a CAGR of 6.4%.

3. Which product segment dominates the market?

Blood collection tubes and needles & syringes hold a significant share due to their widespread use in diagnostic procedures.

4. Which region leads the blood collection market?

North America currently dominates due to advanced healthcare infrastructure and high diagnostic testing rates.

5. What are the key growth drivers?

Major drivers include rising infectious diseases, increasing chronic disease burden, expansion of blood banks, and technological advancements in automated blood collection systems.